Nano X opened higher at $0.37, compared with its previous close of $0.36. In the last trading session, the stock traded between $0.31 and $0.38. It showed a downward intraday trend.
An investment of $100 made 5 years ago in Nano X is now worth
$ 1.33
Resulting in a loss of
$ 98.67 (98.67%)
Note: Past profits do not guarantee future returns.
No analyst rating data available.
Today's Change
$-0.05 (-13.71%)
Day High
$0.38
Day Low
$0.31
Day Open
$0.37
Prev Close
$0.36
Volume
26,04,606
1W Return
10.95%
1M Return
-38.07%
3M Return
-71.58%
6M Return
-80.74%
1Y Return
-89.87%
Market Cap ($ Mn)
25
PE Ratio
-
PB Ratio
0.46
PEG Ratio
-
ROE
-45.39%
ROCE
-45.51%
EPS (TTM)
$-0.79
1 Week
10.95%
1 Month
-38.07%
3 Months
-71.58%
6 Months
-80.74%
9 Months
-85.98%
Nano-X Imaging stock jumps 38% as subsidiary signs Thailand deal
Shares rose 38.53% to $0.32 following a distribution agreement for cardiac CT software in Thailand. Board approved a plan to cut annualized operating expenses by 25% to 30% compared to 2026 levels. Nanox.AI partnered with Dosy Health to distribute HealthCCSng, subject to regulatory approvals. Company faces substantial doubt about going concern status despite cost-cutting initiatives.
2 days agoNanox subsidiary USARAD expands AZmed AI integration in radiology
Nanox subsidiary USARAD expands its collaboration with AZmed. Integrates FDA-cleared Rayvolve AI suite into teleradiology workflows. Expansion covers acute trauma and chest X-ray detection modules. AI tools delivered via Nanox Marketplace and OnePacs platform. Clinical validation based on 258,373 X-rays from 100 centers.
3 days agoNanox.ARC X selected as one of TIME’s best inventions of 2026
Nanox.ARC X selected for TIME's Best Inventions of 2026. System delivers 3D imaging with up to 80% less radiation than CT. First inclusion on main TIME list; previous mention in 2024 for AI solutions. Distribution agreements active in US, Europe, and Latin America.
28 days agoNano X Imaging Q2 Results: Sales up 36% YoY, EPS misses estimates
Adjusted EPS of $(0.17) missed the $(0.16) estimate by 6.25%. Revenue rose 36.71% YoY to $4.156 million. Sales missed the $5.385 million consensus estimate by 22.83%. Loss per share unchanged from the same period last year.
2mo agoNano-X Impact signs New England distribution deal for Nanox.ARC
Nano-X Impact signs distribution deal with Associated X-Ray Imaging Corp. Agreement covers marketing and support for FDA-cleared Nanox.ARC system. Deployment focuses on outpatient and community clinics in New England. Partnership leverages partner's existing MRI, CT, and X-ray infrastructure.
2mo agoNanox signs exclusive UK reseller deal for HealthOST with Vertec
Nanox Imaging's subsidiary Nanox AI has signed an exclusive three-year reseller agreement with Vertec Scientific to commercialize HealthOST in the UK. The deal is subject to minimum annual license commitments and leverages Vertec's established DXA infrastructure.
2mo ago| Stock | LTP | Change % | Market Cap | PE |
|---|---|---|---|---|
| $109.29 | -1.06% | $1,89,283.94M | 36.28 | |
| $449.53 | -0.11% | $1,55,826.88M | 42.73 | |
| $101.61 | +0.02% | $1,29,976.46M | 24.46 | |
| $318.79 | -1.70% | $1,21,360.48M | 34.27 | |
| $45.13 | +0.96% | $65,414.72M | 18.96 | |
| $105.81 | +1.73% | $60,840.75M | 53.70 | |
| $214.52 | +0.90% | $58,432.46M | 44.07 | |
| $82.60 | -1.26% | $37,346.60M | 16.49 | |
| $42.16 | +3.06% | $37,044.18M | 89.05 | |
| $72.46 | -2.16% | $35,027.16M | 54.55 | |
| $237.20 | +1.61% | $33,458.08M | 23.04 | |
| $80.35 | +0.53% | $29,964.75M | 36.04 |
An investment of $100 made 5 years ago in Nano X is now worth
$ 1.33
Resulting in a loss of
$ 98.67 (98.67%)
Note: Past profits do not guarantee future returns.
